Against the Clock: the Bundibugyo Ebola Outbreak
Summary
Research into new Ebola vaccines and therapeutics, ranging from prophylaxis to post-exposure prophylaxis treatment candidates, are being fast-tracked, using similar mechanisms to fast-tracked COVID-19 trials. Even so, there are legitimate concerns that the Bundibugyo strain of the Ebola virus is moving faster than the response of technology developers, regulators, governments, and international organizations.Table of Contents
- Key findings
- Central African countries are again facing a serious outbreak of Ebola
- Vaccine and therapeutic research
- Disclaimer
